Paul Williams

7.2k total citations
34 papers, 620 citations indexed

About

Paul Williams is a scholar working on Psychiatry and Mental health, Pathology and Forensic Medicine and Social Psychology. According to data from OpenAlex, Paul Williams has authored 34 papers receiving a total of 620 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Psychiatry and Mental health, 7 papers in Pathology and Forensic Medicine and 7 papers in Social Psychology. Recurrent topics in Paul Williams's work include Migraine and Headache Studies (8 papers), Trigeminal Neuralgia and Treatments (6 papers) and Neuroendocrine regulation and behavior (6 papers). Paul Williams is often cited by papers focused on Migraine and Headache Studies (8 papers), Trigeminal Neuralgia and Treatments (6 papers) and Neuroendocrine regulation and behavior (6 papers). Paul Williams collaborates with scholars based in United States, United Kingdom and Netherlands. Paul Williams's co-authors include Duna Penn, Alexander Cacciarelli, M. David Curtis, C. Eugene Reeder, David W. Dodick, Roger Freidinger, Bradley V. Clineschmidt, Douglas J. Pettibone, Giorgio Sandrini and Jill M. Erb and has published in prestigious journals such as PEDIATRICS, Journal of Medicinal Chemistry and Inorganic Chemistry.

In The Last Decade

Paul Williams

31 papers receiving 572 citations

Peers

Paul Williams

PMH

PRM

PFM

PPCH

Stephanie Wall United States

Malini Iyengar United States

Mansel Aylward United Kingdom

Atsuyoshi Mori Japan

Seonghoon Ko South Korea

Sally Fletcher United Kingdom

Kevin F Foley United States

S Gepi-Attee United Kingdom

Don C. McKenzie Canada

Jamie Myers United States

Stephanie Wall United States

Paul Williams

140 ×0.8

PMH

80 ×0.5

PRM

23 ×0.2

PFM

40 ×0.4

PPCH

278 ×3.2

Citations per year, relative to Paul Williams Paul Williams (= 1×) peers Stephanie Wall

Countries citing papers authored by Paul Williams

Since Specialization

Citations

This map shows the geographic impact of Paul Williams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Williams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Williams more than expected).

Fields of papers citing papers by Paul Williams

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Williams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Williams. The network helps show where Paul Williams may publish in the future.

Co-authorship network of co-authors of Paul Williams

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Williams. A scholar is included among the top collaborators of Paul Williams based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Williams. Paul Williams is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Smith, Adam B., Darren C. Greenwood, Mike Horton, et al.. (2024). Psychometric analysis of the modified COVID-19 Yorkshire Rehabilitation Scale (C19-YRSm) in a prospective multicentre study. BMJ Open Respiratory Research. 11(1). e002271–e002271. 7 indexed citations

Sivan, Manoj, Thomas Osborne, Paul Williams, et al.. (2024). Long COVID Clinical Severity Types Based on Symptoms and Functional Disability: A Longitudinal Evaluation. Journal of Clinical Medicine. 13(7). 1908–1908. 5 indexed citations

Ivanics, Tommy, et al.. (2020). Contemporary management of chronic indwelling inferior vena cava filters. Journal of Vascular Surgery Venous and Lymphatic Disorders. 9(1). 163–169. 2 indexed citations

Dodick, David W., Giorgio Sandrini, & Paul Williams. (2007). Use of the Sustained Pain-Free Plus No Adverse Events Endpoint in Clinical Trials of Triptans in Acute Migraine. CNS Drugs. 21(1). 73–82. 29 indexed citations

Chengappa, KN Roy & Paul Williams. (2005). Barriers to the effective management of bipolar disorder: a survey of psychiatrists based in the UK and USA. Bipolar Disorders. 7(s1). 38–42. 15 indexed citations

Williams, Paul & C. Eugene Reeder. (2004). A Comparison of the Cost-Effectiveness of Almotriptan and Sumatriptan in the Treatment of Acute Migraine Using a Composite Efficacy/Tolerability End Point. Journal of Managed Care Pharmacy. 10(3). 259–265. 21 indexed citations

Dodick, David W., Richard B. Lipton, Michel D. Ferrari, et al.. (2004). Prioritizing treatment attributes and their impact on selecting an oral triptan: Results from the TRIPSTAR project. Current Pain and Headache Reports. 8(6). 435–442. 15 indexed citations

Cutrer, F. Michael, Peter J. Goadsby, Michel D. Ferrari, et al.. (2004). Priorities for triptan treatment attributes and the implications for selecting an oral triptan for acute migraine: a study of US primary care physicians (the TRIPSTAR project). Clinical Therapeutics. 26(9). 1533–1545. 19 indexed citations

Williams, Paul & C. Eugene Reeder. (2003). Cost-effectiveness of almotriptan and rizatriptan in the treatment of acute migraine. Clinical Therapeutics. 25(11). 2903–2919. 19 indexed citations

10.

Williams, Paul. (2003). A Vision of Progress and Nostalgia: the Halifax Memorial Tower. International Journal of Heritage Studies. 9(3). 243–265. 1 indexed citations

11.

Williams, Paul, Andrew Dowson, Alan M. Rapoport, & J. Sawyer. (2001). The Cost Effectiveness of Stratified Care in the Management of Migraine. PharmacoEconomics. 19(8). 819–829. 27 indexed citations

12.

Williams, Paul & D. J. PETTIBONE. (1996). Recent Advances in the Development of Oxytocin Receptor Antagonists. Current Pharmaceutical Design. 2(1). 41–58. 7 indexed citations

13.

Williams, Paul, Bradley V. Clineschmidt, Jill M. Erb, et al.. (1995). 1-[1-[4-[(N-Acetyl-4-piperidinyl)oxy]-2- methoxybenzoyl]piperidin-4-yl]-4H-3,1- benzoxazin-2(1H)-one (L-371,257): a new, orally bioavailable, non-peptide oxytocin antagonist.. Journal of Medicinal Chemistry. 38(23). 4634–4636. 51 indexed citations

14.

Williams, Paul, et al.. (1992). Comparative pharmacological profile of muscarinic agonists in the isolated ileum, the pithed rat, and the mouse charcoal meal transit test. General Pharmacology The Vascular System. 23(2). 177–185. 8 indexed citations

15.

Williams, Paul, et al.. (1991). General pharmacology of a new potent 5-hydroxytryptamine antagonist.. PubMed. 41(3). 189–95.

16.

Bock, Mark G., Robert M. DiPardo, Paul Williams, et al.. (1990). Receptor ligands which bind the oxytocin receptor with selectivity and high affinity. Chemical modification of a Streptomyces silvensis derived cyclic hexapeptide. Journal of Medicinal Chemistry. 33(9). 2321–2323. 26 indexed citations

17.

Freidinger, Roger, Paul Williams, Roger D. Tung, et al.. (1990). Cyclic hexapeptide oxytocin antagonists. Potency-, selectivity-, and solubility-enhancing modifications. Journal of Medicinal Chemistry. 33(7). 1843–1845. 15 indexed citations

18.

Williams, Paul & M. David Curtis. (1986). Synthesis and structure of Cp2Cp12Mo4S4 cubane clusters: an affirmation of the Dahl binding model. Inorganic Chemistry. 25(25). 4562–4570. 45 indexed citations

19.

Williams, Paul, et al.. (1983). Sulindac versus piroxicam in the treatment of osteoarthritis. Current Medical Research and Opinion. 8(6). 434–440. 6 indexed citations

20.

Seibert, Charles E., et al.. (1981). Progressive Posttraumatic Cystic Myelopathy. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact